Eptinezumab (ALD-403) is a human monoclonal antibody targeting the alpha and beta subtypes of human calcitonin gene-related peptide (CGRP). Eptinezumab binds to the CGRP ligand and blocks its binding to endogenous CGRP receptors, thereby inhibiting receptor activation. Eptinezumab can be used in research related to migraine[1].
Molekulargewicht:
(143.36 kDa)
Reinheit:
99.90
CAS Nummer:
[1644539-04-7]
Target-Kategorie:
CGRP Receptor
Anwendungsbeschreibung:
MCE Product type: Inhibitory Antibodies
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten